Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tisseel vs DuraSeal in Cranial Surgery
NCT02891070Phase 3Completed
- Sponsor
- Baxter
- Start
- Oct 2016
- Primary completion
- Aug 2018
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
Phase 3, randomised, single-blind trial of tisseel in cerebrospinal fluid leak (2 arms), sponsored by Baxter. Primary endpoint: Number of Participants With No CSF Leak During and After Surgery. Started Oct 2016; status: completed.
02
Drugs
tisseel
03
Conditions
cerebrospinal fluid leak
Beyond the preview
Go deeper on NCT02891070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02891070.